Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Revenue

Fate Therapeutics had revenue of $6.48M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.93M. In the year 2023, Fate Therapeutics had annual revenue of $63.53M.

• Revenue (ttm): $6.48M
• Revenue Growth: -95.27%
• P/S Ratio: 75.03
• Revenue / Employee: $35,790
• Employees: 181
• Market Cap: 486.06M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	63.53M	-32.77M	-34.03%
Dec 31, 2022	96.30M	40.45M	72.44%
Dec 31, 2021	55.85M	24.41M	77.66%
Dec 31, 2020	31.43M	20.75M	194.33%
Dec 31, 2019	10.68M	5.94M	125.32%
Dec 31, 2018	4.74M	634.00K	15.44%
Dec 31, 2017	4.11M	-296.00K	-6.72%
Dec 31, 2016	4.40M	1.97M	81.08%
Dec 31, 2015	2.43M	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	971.00K	-1.70M	-63.63%
Dec 31, 2012	2.67M	1.50M	128.21%
Dec 31, 2011	1.17M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.